Literature DB >> 6167674

Degradation of the P0, P1, and Pr proteins in peripheral nervous system myelin by plasmin: implications regarding the role of macrophages in demyelinating diseases.

W Cammer, C F Brosnan, B R Bloom, W T Norton.   

Abstract

Activated macrophages secrete a variety of neutral proteinases, including plasminogen activator. Since macrophages are implicated in primary demyelination in the peripheral nervous system (PNS) in Guillain-Barré syndrome and experimental allergic neuritis, we have investigated the ability of plasmin and of conditioned media from cultured macrophages, in the presence of plasminogen, to degrade the proteins in bovine and rat PNS myelin. The results indicate that (a) the major glycoprotein P0 and the basic P1 and Pr proteins in PNS myelin are extremely sensitive to plasmin, perhaps more so than is the basic protein in CNS myelin; (b) the initial product of degradation of P0 by plasmin has a molecular weight higher than that of the "X" protein; (c) large degradation products of P0 are relatively insensitive to further degradation; and (d) the neuritogenic P2 protein in PNS myelin is quite resistant to the action of plasmin. Results similar to those with plasmin were obtained with conditioned media from macrophages and macrophage-like cell lines together with plasminogen activator, and the degradation of the PNS myelin proteins, Po and P1, under these conditions was inhibited by p-nitrophenylguanidinobenzoate, an inhibitor of plasmin and plasminogen activator. The results suggest that the macrophage plasminogen activator could participate in inflammatory demyelination in the PNS.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6167674     DOI: 10.1111/j.1471-4159.1981.tb00593.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

Review 1.  Autoimmune responses in peripheral nerve.

Authors:  H P Hartung; H Willison; S Jung; M Pette; K V Toyka; G Giegerich
Journal:  Springer Semin Immunopathol       Date:  1996

Review 2.  Proteinases in inflammatory demyelinating disease.

Authors:  C T Bever; J N Whitaker
Journal:  Springer Semin Immunopathol       Date:  1985

3.  Proteolysis of peripheral nerve myelin in acute experimental allergic neuritis.

Authors:  K Schott; M Schabet; A Stevens; R Bühler; H Wiethölter
Journal:  Neurochem Res       Date:  1990-09       Impact factor: 3.996

4.  Cyclic AMP-stimulated protein kinase activity in rabbit peripheral myelin.

Authors:  V Zabrenetzky; V Krygier-Brévart; P S Spencer
Journal:  Neurochem Res       Date:  1984-01       Impact factor: 3.996

5.  Degradation of bovine P2 protein by bovine brain cathepsin D.

Authors:  J N Whitaker; J M Seyer
Journal:  Neurochem Res       Date:  1984-10       Impact factor: 3.996

6.  Suppression of experimental allergic encephalomyelitis (EAE) with liposome-encapsulated protease inhibitor: therapy through the blood-brain barrier.

Authors:  T Osanai; Y Nagai
Journal:  Neurochem Res       Date:  1984-10       Impact factor: 3.996

7.  Dominant-negative effect on adhesion by myelin Po protein truncated in its cytoplasmic domain.

Authors:  M H Wong; M T Filbin
Journal:  J Cell Biol       Date:  1996-09       Impact factor: 10.539

Review 8.  Role of Campylobacter jejuni infection in the pathogenesis of Guillain-Barré syndrome: an update.

Authors:  Kishan Kumar Nyati; Roopanshi Nyati
Journal:  Biomed Res Int       Date:  2013-08-13       Impact factor: 3.411

9.  Accumulation of diabetic rat peripheral nerve myelin by macrophages increases with the presence of advanced glycosylation endproducts.

Authors:  H Vlassara; M Brownlee; A Cerami
Journal:  J Exp Med       Date:  1984-07-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.